Comparison of Steroid Dosages on the Efficacy of Trochanteric Bursa InjectionAdjunctive Treatment for Chronic Rhinosinusitis With Nasal PolyposisSuprachoroidal Injection of Triamcinolone Acetonide Using Custom Made Needle to Treat Retinal DisordersMixed Gel of Hydrocortisone and Aluminium Phosphate Preventing Endoscopic Submucosal Dissection Postoperative Stenosis for Patients With Large Esophageal CarcinomaCombined Vitrectomy and Triamcinolone in Macular Edema Secondary to Branch Retinal Vein Occlusion (BRVO)Subacromial Ultrasound-guided or Systemic Steroid Injection for Rotator Cuff Disease, a Randomized Double Blinded StudyComparison of Efficacy Between Silicone Ahmed Glaucoma Valves With and Without Intravitreal Triamcinolone InjectionAdrenal Function and Use of Intralesional Triamcinolone Acetonide 10 mg/mL (Kenalog-10) in Patients With Alopecia AreataStudy of Triamcinolone Acetonide on the Growth Velocity of Children, Ages 3 to 9, With Perennial Allergic Rhinitis (PAR)Combination Therapy for Neovascular Age Related Macular DegenerationLaser-Ranibizumab-Triamcinolone for Proliferative Diabetic RetinopathyLaser-Ranibizumab-Triamcinolone for Diabetic Macular EdemaTriamcinolone as Adjunctive Treatment to Laser Panretinal Photocoagulation for Proliferative Diabetic RetinopathySequentially Combined Vitrectomy, IVTA and Macular Focal Laser Photocoagulation for Diabetic Macular EdemaTo Compare Therapeutic Effect of Intravitreal Bevacizumab and Triamcinolone in Resistant Uveitic Cystoid Macular EdemaEffect of Intravitreal Bevacizumab on Clinically Significant Macular EdemaIntravitreal Avastin Versus Intravitreal Avastin and Triamcinolone in Central Retinal Vein Occlusion(CRVO)Combined PDT and Intravitreal Bevacizumab vs Combination of PDT, Intravitreal Bevacizumab and Triamcinolone for Neovascular AMDBevacizumab Versus Combined Bevacizumab and Triamcinolone for Refractory Diabetic Macular Edema; a Randomized Clinical TrialIntravitreal Bevacizumab vs. Bevacizumab Combined With Triamcinolone for Neovascular AMDIntravitreal Triamcinolone for Acute Branch Retinal Vein OcclusionA Randomized, Placebo-Controlled Clinical Trial of Intravitreal Triamcinolone for Refractory Diabetic Macular EdemaA Pilot Study of Peribulbar Triamcinolone Acetonide for Diabetic Macular EdemaIntravitreal Triamcinolone Acetonide Versus Laser for Diabetic Macular EdemaEfficacy, Safety and Tolerability of Repeated Dosis of Intravitreous Bevacizumab in Uveitic Macular OedemaThe Effectiveness of Selective Nerve Root Injections in Preventing the Need for SurgeryBotulinum Toxin Type A (BT-A) in Hemiplegic Shoulder Pain Versus SteroidMorphological and Functional Evaluation of Irvine-Gass SyndromeSubacromial Injection With Corticosteroid Versus Nonsteroidal Anti-inflammatory Drugs (NSAID) in Shoulder Impingement SyndromePostoperative Pain Control Following Vitreoretinal SurgeryThe Efficacy of Topical Sesame Oil Versus Topical Triamcinolone on Oral Lichen Planus and Salivary Level of Oxidative Stress Biomarker [MDA]Long Term Effectiveness of Trigger Finger Injections With Triamcinolone vs. DexamethasoneEconomic Impact of Dropless Therapy Versus Usual Care for Cataract Surgery: A Real-World Study.Steroid Injections vs. Standard Treatment for Macular Edema Due to Retinal Blood Vessel BlockageTreatment of Diabetic Macular Edema: Triamcinolone Injections Vs. Laser PhotocoagulationThe Standard Care vs. COrticosteroid for REtinal Vein Occlusion (SCORE) StudyTopical 5% Minoxidil and Potent Topical Corticosteroid Versus Intralesional Corticosteroid in the Treatment of Alopecia AreataPropel Stent vs Kenalog-soaked Nasopore After Frontal Drill-outTreatment Modalities of Oral Lichen PlanusPlantar Fasciitis Randomized Clinical Control Trial
P4844
Q61894676-B3F79FDF-C7B7-4DD7-B99F-6F65ECFE2CB5Q61907155-90556AA5-C6D0-40FD-AE35-C0C841B06777Q61907193-D55FB3E1-9CD5-4EC0-BB1F-9F153F23109BQ61908812-FB0DBB19-F607-4760-9784-447C13316EE5Q61914749-F69DC64B-3D4E-4F9F-9F4D-5D4D36AFD105Q61914911-CDC181D8-72BA-4F9E-81C7-F87C0C057A16Q61917945-F70D9F8E-4388-453B-9EB2-3C6A12D7D971Q61918580-5537FCFE-E821-4510-B2DB-B9372C0686EEQ61923077-03E6E32F-1953-4EA1-A71E-ED2C69B38B44Q61924362-AAE843E0-0A6C-4A26-8ED2-BCBBF6969AAFQ61924668-0219C262-501B-4023-BBDD-E6FCDB1089DBQ61924722-AE64A19F-050B-4E20-B2F5-761AB61C34FBQ61924860-4C61B28E-E5FE-44B4-8951-D025B986BB04Q61933163-00E76699-A5FE-42C5-B1FB-C58CCB112F07Q61933211-5D92FD9D-5288-4B56-AF17-F08CD5C9F856Q61933287-89CD6A2C-06BB-4090-A5DF-C8941E65CCD5Q61933295-590E6322-4461-4C20-A5F4-2F328413F8CCQ61933311-53D92484-9A03-4FBE-829F-F94922A9C002Q61933328-D83011B2-5BD7-4766-8141-4FD5F4F73F6AQ61933336-FDBAAC5C-8EAE-4EBF-92AA-AB6B090B48E9Q61933369-8FBD9F11-5A7F-41FF-B542-A86B8E23E3B7Q61933454-282E7BF4-3764-4029-A7D2-4A318F966920Q61933538-E6FCFF0A-B5C9-4D2D-9EF8-ECEDB0D9D572Q61933964-7FFB14CD-8AA9-4065-9E31-242564AA68EBQ61936625-66B84FF1-BB3D-40FB-8800-9BB5CBC4DDECQ61938398-85100CCE-C027-4FD5-A353-1E3D439FE076Q61955364-33211260-CDC4-44F8-A4F2-F778C3878701Q61957335-E6F6FD58-A1DD-4967-B063-E563F16121CCQ61967593-741079CF-8B59-4A5D-B69F-31EFE1B514A9Q61969721-98E33C3C-0456-4439-8149-48017A40E366Q62035337-5FC5C537-9857-4E54-A954-4F2F199D9E34Q62062857-1A5C9572-7B41-411D-9FAA-A663D7DA2D80Q62062927-5109555C-BDBC-4E67-A093-CEE0F2637012Q62105729-940A693D-D3A2-490F-8D95-D711356FEF1FQ62105788-F04BBCDD-FD08-43C3-8535-FF132CAF99E5Q62105818-F032223C-25D8-402A-A63F-AB8F0B25900BQ62814601-830BCCF5-78C1-4E4C-A6C1-D6A1E9F82BFEQ62814957-71CDB1DD-E9CF-4542-8BDB-8913598F8F4DQ63010959-4685CB0E-F539-433E-BE2A-0E131CB144F2Q63012462-08B89868-1E57-4687-8B48-D992E11CEFFD
P4844
description
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de
chemische Verbindung
@de-ch
chemische verbinding
@nl
name
triamcinolone diacetate
@en
type
label
triamcinolone diacetate
@en
prefLabel
triamcinolone diacetate
@en
P486
P592
P661
P662
P683
P2017
CC(=O)OCC(=O)[C@]1([C@@H](C[C@ ...... =O)C=C[C@@]43C)F)O)C)OC(=O)C)O
P2067
P2115
N0000145979
P2167
P231
P232
P233
CC(=O)OCC(=O)C1(C(CC2C1(CC(C3(C2CCC4=CC(=O)C=CC43C)F)O)C)OC(=O)C)O
P234
1S/C25H31FO8/c1-13(27)33-12-20 ...... ,19-,21+,22-,23-,24-,25+/m0/s1
P235
XGMPVBXKDAHORN-RBWIMXSLSA-N
P2566
100.000.608